Mitesh

Community Pharmacy England on behalf of pharmacy owners made further applications to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), resulting in a further 7 new products being added to the ‘Drugs for which Discount is Not Deducted’ (DND) list from 1 February 2025. This takes the total [...]

The post 7 products added to the Discount Not Deducted (DND) list from February 2025 appeared first on Community Pharmacy England.

Update 08/05/25 – The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocol (SSP) for Cefalexin 250mg/5ml oral suspension sugar free (SSP078), which has been reactivated due to supply issues. SSP078 is now due to expire on Friday 8 August 2025. Community Pharmacy England’s in-house Drug Tariff and [...]

The post Reactivation of SSP078 for Cefalexin 250mg/5ml oral suspension sugar free appeared first on Community Pharmacy England.

Drug alert number: EL (25)A/04 Date issued: 30 January 2025 Bristol Laboratories Limited is recalling the batches specified in the table as a precautionary measure due to possible microbial contamination. Amlodipine Bristol Lab 2.5 mg Tablets, PL 17907/0435 SNOMED Code: 38095611000001108 Batch Number Expiry Date Pack Size First Distributed MF23016 July 2025 28 29/9/2023 MF23017 [...]

The post MHRA Class 2 Medicines Recall: Amlodipine Bristol Lab 2.5mg tablets (Bristol Laboratories Limited) appeared first on Community Pharmacy England.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 18 Issue 6 January 2025) has been published and includes articles on: GLP-1 and dual GIP/GLP-1 receptor agonists: potential risk of pulmonary aspiration during general anaesthesia or deep sedation Letters and medicine recalls sent to healthcare professionals in December 2024 To see the latest [...]

The post MHRA Drug Safety Update: January 2025 appeared first on Community Pharmacy England.

Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has agreed to retrospectively adjust the reimbursement price of Gaviscon Infant oral powder 15 dual dose sachets for EPS prescriptions dispensed between May 2023 to November 2024. The term ‘dual dose sachets’ was updated to [...]

The post Retrospective reimbursement price adjustments for Gaviscon Infant oral powder sachets appeared first on Community Pharmacy England.